Cargando…
Use of Leukoreduced Blood Does Not Reduce Infection, Organ Failure, or Mortality Following Trauma
BACKGROUND: Leukoreduced (LR) blood has been demonstrated to reduce morbidity and mortality in high-risk surgical patients, but not in trauma patients. The objective of the present study was to determine the effect of LR blood on morbidity and mortality. We hypothesized that the use of LR blood does...
Autores principales: | Englehart, Michael S., Cho, S. David, Morris, Melanie S., Gee, Arvin C., Riha, Gordon, Underwood, Samantha J., Differding, Jerome A., Luem, Nick D., Wiesberg, Tracy T., Boshkov, Lynn K., Schreiber, Martin A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101844/ https://www.ncbi.nlm.nih.gov/pubmed/19452207 http://dx.doi.org/10.1007/s00268-009-0076-5 |
Ejemplares similares
-
Leukoreduced blood components: Advantages and strategies for its implementation in developing countries
por: Sharma, R. R., et al.
Publicado: (2010) -
Hemolysis of irradiated leukoreduced red blood cells during rapid warming: An in vitro experimental study
por: Lee, Sukyung, et al.
Publicado: (2015) -
Association of CTLA4 Gene Polymorphism with Transfusion Reaction after Infusion of Leukoreduced Blood Component
por: Wen, Ying-Hao, et al.
Publicado: (2019) -
The Influence of CD28 Gene Polymorphism in Transfusion Reaction after Transfusing Leukoreduced Blood Components
por: Chen, Ding-Ping, et al.
Publicado: (2020) -
Microcirculation and blood transfusions during sepsis: leukoreduced (LR) versus non-LR red blood cells
por: Donati, A, et al.
Publicado: (2013)